NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院

Clinical TrialsSearch results

Search

Number of results: 66000
  • Recruitment status
  • Title of the study
  • Health Condition
  • Primary sponsor
  • Date of registration
  • Other

  • Type 2 diabetes mellitus with renal dysfunction
  • Taisho Pharmaceutical co., LTD
  • 2010-09-10
  • Other

  • Type 2 diabetes mellitus whose blood glucose levels are not adequately controlled by pioglitazone in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2010-07-23
  • Other

  • Type 2 diabetes mellitus whose blood glucose levels are not adequately controlled by metformin in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2010-07-23
  • Other

  • Type 2 diabetes mellitus whose blood glucose levels are not adequately controlled by metformin in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2010-07-23
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by sulfonylurea drugs taken in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2005-09-12
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by pioglitazone in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2010-07-23
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2008-01-30
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2005-11-25
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2005-09-12
  • Other

  • Type 2 diabetes mellitus patients whose blood glucose levels are not adequately controlled by alpha-glucosidase inhibitor in addition to diet and exercise therapies
  • Dainippon Sumitomo Pharma Co., Ltd.
  • 2006-08-23

Progress situation









The subject of age and gender

Sex



Age











Clinical Study Category (based on jRCT)